UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934

Filed by the Registrant  ☒

Filed by a Party other than the Registrant  ☐

Check the appropriate box:

☐Preliminary Proxy Statement

☐Confidential, for Use of the Commission Only (as permitted by Rule 14a–6(e)(2))

☐Definitive Proxy Statement

☒Definitive Additional Materials

☐Soliciting Material Pursuant to § 240.14a–12

AXOGEN, INC.

(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒No fee required.

☐Fee computed on table below per Exchange Act Rules 14a–6(i)(1) and 0–11.

☐Fee paid previously with preliminary materials.

☐Check box if any part of the fee is offset as provided by Exchange Act Rule 0–11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

 

 

AxoGen, Inc. (the "Company") is supplementing the proxy statement for its 2018 annual meeting of shareholders, which was filed on March 29, 2018, to include the Amended and Restated Articles of Incorporation of AxoGen, Inc. (the “Articles”). The Articles are referenced in the proxy statement as Appendix A, but were inadvertently omitted from the proxy statement.  In addition, incorrect website references were provided in the proxy statement under “Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting to Be Held on May 14, 2018.”  The proxy statement, the accompanying Notice of Annual Meeting and proxy card, our Annual Report on Form 10–K and this Appendix A are also available at our website at https://ir.axogeninc.com/sec-filings. 

 

APPENDIX A

 

AMENDED AND RESTATED

ARTICLES OF INCORPORATION

OF

AXOGEN INC.

 

ARTICLE 1. NAME

 

The name of the corporation is “AxoGen Inc.”

 

ARTICLE 2. REGISTERED OFFICE

 

The address of the registered office of the corporation in Minnesota is Corporation Service Company, 2345 Rice Street, Roseville, MN 55113.

 

ARTICLE 3. AUTHORIZED SHARES

 

The aggregate number of authorized shares of the corporation is 100,000,000, $0.01 par value per share, which shall be divisible into the classes and series, have the designations, voting rights, and other rights and preferences and be subject to the restrictions that the Board of Directors of the corporation may from time to time establish, fix, and determine consistent with Articles 4 and 5 hereof and as permitted by law. Unless otherwise designated by the Board of Directors, all issued shares shall be deemed Common Stock with equal rights and preferences.

 

ARTICLE 4. NO CUMULATIVE VOTING

 

There shall be no cumulative voting by the shareholders of the corporation.

 

ARTICLE 5. NO PREEMPTIVE RIGHTS

 

The shareholders of the corporation shall not have preemptive rights to subscribe for or acquire securities or rights to purchase securities of any kind, class, or series of the corporation.

 

ARTICLE 6. WRITTEN ACTION BY DIRECTORS

 

An action required or permitted to be taken at a meeting of the Board of Directors of the corporation may be taken by a written action signed, or consented to by authenticated electronic communication, by all of the directors unless the action need not be approved by the shareholders of the corporation, in which case the action may be taken by a written action signed, or consented to by authenticated electronic communication, by the number of directors that would be required to take the same action at a meeting of the Board of Directors of the corporation at which all of the directors were present.

 

ARTICLE 7. DIRECTOR LIABILITY

 

To the fullest extent permitted by the Minnesota Business Corporation Act as the same exists or may hereafter be amended, a director of this corporation shall not be personally liable to the corporation or its shareholders for monetary damages for breach of fiduciary duty as a director. Neither the amendment, modification or repeal of this Article nor the adoption of any provision in these articles of incorporation inconsistent with this Article shall adversely affect any right or protection of a director or officer of the corporation with respect to any act or omission that occurred prior to the time of such amendment, modification, repeal or adoption.